ADIPOQ and Hyperglycemia: Circulating levels of adiponectin were notably reduced (hypoadiponectinemia) under conditions of obesity, IR, and T2DM, whereas overexpression or administration of adiponectin improved overall insulin action and reversed hyperglycemia in obese mice, independent of plasma insulin levels [52, 53].